Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL? - Top-Institutions - MDSpire

Can Lymphocytosis Detected in Bronchoalveolar Lavage Serve as a Prognostic Indicator in Fibrotic Hypersensitivity Pneumonitis, and Does Low-Dose Immunomodulatory Therapy Affect This Correlation?

  • By

  • Punchalee Kaenmuang

  • Fiammetta Danzo

  • Simon Bax

  • Richard J. Hewitt

  • Maria Kokosi

  • Vasileios Kouranos

  • Felix Chua

  • Peter M. George

  • Gisli Jenkins

  • Athol U. Wells

  • Carmel J. W. Stock

  • Piersante Sestini

  • Elisabetta A. Renzoni

  • July 21, 2026

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Royal Brompton Hospital
    Royal Brompton Hospital

    London, England

    Key Differentiators

    • Pulmonology

  • #2

    General Hospital of Ningxia Medical University
    General Hospital of Ningxia Medical University

    Yinchuan, Ningxia

    Key Differentiators

    • Pulmonology

Original Source(s)

Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL?

  • by Punchalee Kaenmuang, Fiammetta Danzo, Simon Bax, Richard J. Hewitt, Maria Kokosi, Vasileios Kouranos, Felix Chua, Peter M. George, Gisli Jenkins, Athol U. Wells, Carmel J. W. Stock, Piersante Sestini, Elisabetta A. Renzoni

  • July 21, 2026

Related Content

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.

Do Sitting Patterns Matter?

Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.

High-Dose Vitamin C Could Pose Risk in Severe Burns

“High-dose intravenous vitamin C administered early after injury did not reduce organ dysfunction or [mortality] and should not be a treatment in severe burns.”